Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
The RFK ‘Wild’ Card: Uncertainty For US FDA In A Second Trump Term
Nov 01 2024
•
By
Michael McCaughan
No matter the role Kennedy is given in a potential Trump Administration, he could be a wild card for the FDA and its ability to operate.
(Shutterstock)
More from Elections
More from Agency Leadership